- Home
- HHS vs XCUR Comparison
HHS vs XCUR Comparison
Compare HHS & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.78
N/A
Current Price
$4.26
Company Overview
Basic Information| Metric | HHS | XCUR |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 22.8M |
| IPO Year | 1994 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HHS | XCUR |
|---|---|---|
| Price | $2.78 | $4.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.9K | ★ 12.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $185,242,000.00 | $500,000.00 |
| Revenue This Year | $6.54 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.33 | $3.10 |
| 52 Week High | $5.39 | $15.87 |
Technical Indicators
Market Signals| Indicator | HHS | XCUR |
|---|---|---|
| Relative Strength Index (RSI) | 44.65 | 50.04 |
| Support Level | $2.33 | $3.48 |
| Resistance Level | $3.03 | $4.23 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 26.93 | 78.29 |
Price Performance
Historical Comparison HHS
XCUR
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.